Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jorge Marrero, MD
University of Pennsylvania Medical Center
Principal Investigator - Josep Llovet, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hebrew University- Hadassah Medical Center
Jerusalem, Israel
- Cedars- Sinai Medical Center
Los Angeles, California, United States
- University of California Los Angeles
Los Angeles, California, United States
- Kaiser Permanente Northern California
San Francisco, California, United States
- University of California- San Francisco
San Francisco, California, United States
- Stanford University School of Medicine
Stanford, California, United States
- University of Florida
Gainesville, Florida, United States
- Miami Va Healthcare System
Miami, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Maryland, Baltimore
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Nyu Langone Health
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Hospital of the University of Pennsylvania (hup)
Philadelphia, Pennsylvania, United States
- Baylor Scott & White Research Institute
Dallas, Texas, United States
- the University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 May 2019
- Primary completion
- 25 Aug 2023
- Completion
- 31 Dec 2025
- Last update posted
- 13 Mar 2025
- Registered enrollment
- 766
- Registry id
- NCT03878550
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.